Landsberg Bennett & Dubbaneh’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $975K | Sell |
7,727
-158
| -2% | -$19.9K | 0.12% | 124 |
|
|
2021
Q2 | $1.07M | Sell |
7,885
-148
| -2% | -$20.1K | 0.14% | 120 |
|
|
2021
Q1 | $1.1M | Sell |
8,033
-36,159
| -82% | -$4.96M | 0.16% | 116 |
|
|
2020
Q4 | $6.22M | Sell |
44,192
-140
| -0.3% | -$19.7K | 0.95% | 24 |
|
|
2020
Q3 | $4.95M | Sell |
44,332
-7,225
| -14% | -$807K | 0.87% | 27 |
|
|
2020
Q2 | $5.69M | Buy |
51,557
+565
| +1% | +$62.4K | 1.18% | 15 |
|
|
2020
Q1 | $3.87M | Sell |
50,992
-3,597
| -7% | -$273K | 1.08% | 27 |
|
|
2019
Q4 | $5.17M | Sell |
54,589
-792
| -1% | -$75.1K | 1.21% | 17 |
|
|
2019
Q3 | $4.23M | Sell |
55,381
-727
| -1% | -$55.6K | 1.14% | 18 |
|
|
2019
Q2 | $4.95M | Sell |
56,108
-4,235
| -7% | -$374K | 1.3% | 13 |
|
|
2019
Q1 | $5.59M | Buy |
60,343
+28,573
| +90% | +$2.65M | 1.32% | 15 |
|
|
2018
Q4 | $2.28M | Buy |
+31,770
| New | +$2.28M | 0.87% | 30 |
|